Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb

169Citations
Citations of this article
128Readers
Mendeley users who have this article in their library.

Abstract

We reviewed retrospectively the results in 211 consecutive patients who had undergone limb salvage for bone neoplasia with endoprosthetic reconstruction of the proximal femur (96), distal femur (78), proximal tibia (30) and total femur (7). Their mean age was 50 years (11 to 86) and the mean follow-up period was 37.3 months (1 to 204). A total of 35 (16.6%) prostheses failed. Overall, implant survival was 78% (95% confidence interval (CI) 0.29 to 0.54) at five years, 60% (95% CI 0.93 to 2.35) at ten years and 60% (95% CI 1.27 to 3.88) at 15 years. Survivorship of the limb was 97.6% (95% CI 1.73 to 3.35) at ten years. The gender, age, diagnosis and location of the tumour were not prognostic variables for failure. Modular endoprosthetic replacement in the lower limb is a durable long-term reconstructive option, with the implants generally outlasting the patient. ©2006 British Editorial Society of Bone and Joint Surgery.

Cite

CITATION STYLE

APA

Ahlmann, E. R., Menendez, L. R., Kermani, C., & Gotha, H. (2006, June). Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. Journal of Bone and Joint Surgery - Series B. https://doi.org/10.1302/0301-620X.88B6.17519

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free